Steven A. Buckner

1.2k citations

57 papers · 986 indexed · h-index 19

Molecular Biology
Urology top 1%
Organic Chemistry top 10%
Cellular and Molecular Neuroscience top 10%
Physiology

Co-authors: Ivan Milicic Murali Gopalakrishnan A.V. Daza Arthur A. Hancock Michael J. Coghlan Michael E. Brune James P. Sullivan William A. Carroll
Topics: Urinary Bladder and Prostate Research (17 papers)Receptor Mechanisms and Signaling (16 papers)Ion channel regulation and function (12 papers)
Cited by: Urology Sensory Systems Organic Chemistry
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics British Journal of Pharmacology
Partner nations: United States United Kingdom France

In The Last Decade

Steven A. Buckner

54 papers receiving 944 citations

Peers

Countries citing papers authored by Steven A. Buckner

Since Specialization

Citations

This map shows the geographic impact of Steven A. Buckner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Buckner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Buckner more than expected).

Fields of papers citing papers by Steven A. Buckner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Buckner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Buckner. The network helps show where Steven A. Buckner may publish in the future.

Co-authorship network of co-authors of Steven A. Buckner

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Buckner. A scholar is included among the top collaborators of Steven A. Buckner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Buckner. Steven A. Buckner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Review of Risk Analysis and Helicopter Air Ambulance Accidents 2014 ·Air Medical Journal ·(unknown),Steven A. Buckner,(unknown)	10
2	A‐272651, a nonpeptidic blocker of large‐conductance Ca²⁺‐activated K⁺channels, modulates bladder smooth muscle contractility and neuronal action potentials 2007 ·British Journal of Pharmacology ·(unknown),(unknown),(unknown),Ivan Milicic,Arpana Parihar,(unknown),Julie A. Wilkins,Steven A. Buckner,Murali Gopalakrishnan	8
3	Characterization of a novel ATP‐sensitive K ⁺ channel opener, A‐251179, on urinary bladder relaxation and cystometric parameters 2007 ·British Journal of Pharmacology ·(unknown),(unknown),Steven A. Buckner,Kristi L. Whiteaker,Eduardo Molinari,(unknown),(unknown),A.V. Daza,Jorge D. Brioni,William A. Carroll,Kazunobu Matsushita,Mitsuhiko Yamada,Y Kurachi,Murali Gopalakrishnan	19
4	Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs 2006 ·European Journal of Pharmacology ·Ivan Milicic,Steven A. Buckner,A.V. Daza,Michael J. Coghlan,Thomas A. Fey,Michael E. Brune,Murali Gopalakrishnan	14
5	Pharmacological Characterization of the Novel Dihydropyridine Potassium Channel Opener, (9R)-9-(3-Iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the Regulation of Cardiovascular Function in Conscious and Anesthetized Beagle Dogs 2005 ·Journal of Cardiovascular Pharmacology ·Ryan M. Fryer,(unknown),Lee C. Preusser,Michael E. Brune,William A. Carroll,Steven A. Buckner,Char‐Chang Shieh,(unknown),Kennan C. Marsh,Murali Gopalakrishnan,Bryan F. Cox,Glenn A. Reinhart	6
6	Functional characterization of large conductance calcium-activated K + channel openers in bladder and vascular smooth muscle 2004 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·John Malysz,Steven A. Buckner,A.V. Daza,Ivan Milicic,Arturo Perez‐Medrano,Murali Gopalakrishnan	42
7	The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure–activity relationships of 2-amino-4-azaindoles 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sean Turner,William A. Carroll,(unknown),Murali Gopalakrishnan,Michael J. Coghlan,Char‐Chang Shieh,Xufeng Zhang,(unknown),Steven A. Buckner,Ivan Milicic,James P. Sullivan	18
8	Pharmacological characterization of a 1,4‐dihydropyridine analogue, 9‐(3,4‐dichlorophenyl)‐3,3,6,6‐tetramethyl‐3,4,6,7,9,10‐hexahydro‐1,8(2H,5H)‐acridinedione (A‐184209) as a novel K_ATP channel inhibitor 2003 ·British Journal of Pharmacology ·Murali Gopalakrishnan,Thomas R. Miller,Steven A. Buckner,Ivan Milicic,Eduardo Molinari,Kristi L. Whiteaker,Rachel Davis‐Taber,(unknown),Christopher Cassidy,James P. Sullivan,William A. Carroll	9
9	Structure–activity relationship of a novel class of naphthyl amide KATP channel openers 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sean Turner,William A. Carroll,(unknown),Michael E. Brune,Steven A. Buckner,Murali Gopalakrishnan,(unknown),Michael J. Coghlan,Victoria Scott,Neil A. Castle,A.V. Daza,Ivan Milicic,James P. Sullivan	5
10	Preclinical Pharmacology of Fiduxosin, a Novel α1-Adrenoceptor Antagonist with Uroselective Properties 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Arthur A. Hancock,Steven A. Buckner,Michael E. Brune,Timothy A. Esbenshade,(unknown),(unknown),Ivan Milicic,Michael D. Meyer,James F. Kerwin,Michael Williams	38
11	ABT-866, a novel α1A-adrenoceptor agonist with antagonist properties at the α1B- and α1D-adrenoceptor subtypes 2002 ·European Journal of Pharmacology ·Steven A. Buckner,Ivan Milicic,A.V. Daza,Michael D. Meyer,Robert J. Altenbach,Michael Williams,James P. Sullivan,Jorge D. Brioni	11
12	Structure–Activity studies for a novel series of tricyclic dihydropyrimidines as KATP channel openers (KCOs) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Irene Drizin,Mark W. Holladay,(unknown),(unknown),Sujatha M. Gopalakrishnan,Murali Gopalakrishnan,Kristi L. Whiteaker,Steven A. Buckner,James P. Sullivan,William A. Carroll	49
13	A-315456: a selective α1D-adrenoceptor antagonist with minimal dopamine D2 and 5-HT1A receptor affinity 2001 ·European Journal of Pharmacology ·Steven A. Buckner,Ivan Milicic,A.V. Daza,James J. Lynch,Teodozyj Kolasa,Masaki Nakane,James P. Sullivan,(unknown)	9
14	Pharmacological and molecular analysis of ATP-sensitive K+ channels in the pig and human detrusor 2000 ·European Journal of Pharmacology ·Steven A. Buckner,Ivan Milicic,A.V. Daza,Rachel Davis‐Taber,Victoria Scott,James P. Sullivan,Jorge D. Brioni	64
15	α1-Adrenoceptor-induced contractility in rat aorta is mediated by the α1D subtype 1996 ·European Journal of Pharmacology ·Steven A. Buckner,(unknown),(unknown),Sheila M. Knepper,Arthur A. Hancock	114
16	Effects of Selective and Nonselective Alpha-1 -Adrenoceptor Antagonists on Intraurethral and Arterial Pressures in Intact Conscious Dogs 1996 ·Pharmacology ·Michael E. Brune,(unknown),Ivan Milicic,Steven A. Buckner,(unknown),James F. Kerwin,Arthur A. Hancock	29
17	Receptor Interactions of Abbott-81988, A Highly Potent, Non-Peptide Angiotensin-II Antagonist Selective for Type-1 Receptors 1994 ·Journal of Receptor Research ·Arthur A. Hancock,Steven A. Buckner,(unknown),(unknown),(unknown),(unknown),Robert B. Warner,Martin Winn,Thomas M. Zydowsky,(unknown),Daniel J. Kerkman,John F. DeBernardis	1
18	Pharmacological characterization of abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors 1993 ·Life Sciences ·Arthur A. Hancock,Steven A. Buckner,(unknown),(unknown),(unknown),(unknown),Robert B. Warner,Martin Winn,Thomas M. Zydowsky,(unknown),Daniel J. Kerkman,John F. DeBernardis	2
19	2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists 1993 ·Journal of Medicinal Chemistry ·Martin Winn,Biswanath De,Thomas M. Zydowsky,Robert J. Altenbach,Fatima Z. Basha,Steven A. Boyd,Michael E. Brune,Steven A. Buckner,(unknown)	18
20	Novel Adrenergic Compounds. I. Receptor Interactions of ABBOTT-54741 [(5,6-Dihydroxy-l,2,3,4-Tetrahydro-l-Naphthtyl)Imidazoline], an α-Adrenergic Agonist 1989 ·Journal of Cardiovascular Pharmacology ·(unknown),(unknown),Eugene N. Bush,Steven A. Buckner,(unknown)	0

About Steven A. Buckner

Steven A. Buckner is a scholar working on Urology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience, having authored 57 papers that have together received 986 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (17 papers), Receptor Mechanisms and Signaling (16 papers) and Ion channel regulation and function (12 papers). The work is most often cited by research in Urology (335 citations), Sensory Systems (77 citations) and Organic Chemistry (251 citations). Steven A. Buckner has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ivan Milicic, Murali Gopalakrishnan, A.V. Daza, Arthur A. Hancock, Michael J. Coghlan, Michael E. Brune, James P. Sullivan, William A. Carroll, Sheila M. Knepper and Kristi L. Whiteaker. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact